US Stocks
US Options
ETFs
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewI
IGC
IGC Pharma Inc
0.27
-0.01-3.86%Opening12:53 03/06 EST
OPEN/PREV CLOSE0.2821/0.2850
TODAY RANGE0.2710-0.2849
VOL132.86K
MARKET CAP26.25M
52 WEEK RANGE0.2420-0.4985
AVG VOL (3M)599.22K
% TURNOVER0.14%
TURNOVER--
P/E (TTM)-3.5128
% RANGE4.88%
EPS(TTM)-0.0780
P/E(FORWARD)-3.4250
P/B3.114
BVPS0.0880
DIVIDEND--
P/S17.45
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP24.16M
SHARES OUTSTANDING95.82M
NEXT EARNINGS06/25-06/29
FREE FLOAT88.18M
LOT SIZE1
EX-DATE04/19/2013
News
Press Releases
Financial Reports
Profile
NASDAQ·1d ago
Merck KGaA (MKKGY) Lags Q4 Earnings Estimates
TipRanks·02/26 13:49
IGC Pharma files utility patent applications covering AHA framework
TipRanks·02/23 13:49
IGC Pharma expands Phase 2 CALMA trial with new clinical site
Dow Jones·02/23 10:08
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Dow Jones·02/23 10:08
IGC Pharma Price Target Raised to $5.00/Share From $4.75 by Ascendiant Capital
Benzinga·02/23 10:00
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5
TipRanks·02/17 13:52
IGC Pharma issued notice of allowance by CIPO for IGC-AD1
TipRanks·02/09 14:01
IGC Pharma expands Phase 2 CALMA trial with new clinical site
TipRanks·02/02 14:01
IGC Pharma reaches 70% enrollment in Phase 2 CALMA trial of IGC-AD1
TipRanks·01/22 14:11
IGC Pharma expands Phase 2 CALMA trial with new clinical site
Benzinga·01/22 14:04
IGC Pharma Adds Integrative Clinical Trials Site In Brooklyn
TipRanks·01/12 14:45
IGC Pharma expands Phase 2 CALMA trial with new clinical site
Same Industry
Name/Symbol
Change%
Price